474 related articles for article (PubMed ID: 20837957)
1. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.
Ahles TA; Saykin AJ; McDonald BC; Li Y; Furstenberg CT; Hanscom BS; Mulrooney TJ; Schwartz GN; Kaufman PA
J Clin Oncol; 2010 Oct; 28(29):4434-40. PubMed ID: 20837957
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB
Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking.
Ahles TA; Li Y; McDonald BC; Schwartz GN; Kaufman PA; Tsongalis GJ; Moore JH; Saykin AJ
Psychooncology; 2014 Dec; 23(12):1382-90. PubMed ID: 24789331
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.
Jim HS; Phillips KM; Chait S; Faul LA; Popa MA; Lee YH; Hussin MG; Jacobsen PB; Small BJ
J Clin Oncol; 2012 Oct; 30(29):3578-87. PubMed ID: 22927526
[TBL] [Abstract][Full Text] [Related]
7. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
[TBL] [Abstract][Full Text] [Related]
8. Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls.
Ando-Tanabe N; Iwamitsu Y; Kuranami M; Okazaki S; Yasuda H; Nakatani Y; Yamamoto K; Watanabe M; Miyaoka H
Breast Cancer; 2014 Jul; 21(4):453-62. PubMed ID: 22976288
[TBL] [Abstract][Full Text] [Related]
9. Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study.
Chen BT; Sethi SK; Jin T; Patel SK; Ye N; Sun CL; Rockne RC; Haacke EM; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Somlo G; Li D; Yang R; Tan H; Katheria V; Morrison R; Hurria A
Breast Cancer Res; 2018 May; 20(1):38. PubMed ID: 29720224
[TBL] [Abstract][Full Text] [Related]
10. Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study.
Debess J; Riis JØ; Engebjerg MC; Ewertz M
Breast Cancer Res Treat; 2010 May; 121(1):91-100. PubMed ID: 20306129
[TBL] [Abstract][Full Text] [Related]
11. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study.
Collins B; MacKenzie J; Tasca GA; Scherling C; Smith A
Psychooncology; 2013 Jul; 22(7):1517-27. PubMed ID: 22936651
[TBL] [Abstract][Full Text] [Related]
12. The effects of hormone therapy on cognition in breast cancer.
Shilling V; Jenkins V; Fallowfield L; Howell T
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):405-12. PubMed ID: 14623538
[TBL] [Abstract][Full Text] [Related]
13. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR
J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304
[TBL] [Abstract][Full Text] [Related]
14. Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial.
Schilder CM; Seynaeve C; Beex LV; Boogerd W; Linn SC; Gundy CM; Huizenga HM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
J Clin Oncol; 2010 Mar; 28(8):1294-300. PubMed ID: 20142601
[TBL] [Abstract][Full Text] [Related]
15. Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer.
Boele FW; Schilder CM; de Roode ML; Deijen JB; Schagen SB
Menopause; 2015 Jan; 22(1):17-25. PubMed ID: 24977455
[TBL] [Abstract][Full Text] [Related]
16. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
Psychooncology; 2012 May; 21(5):479-87. PubMed ID: 21351188
[TBL] [Abstract][Full Text] [Related]
17. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.
Jenkins V; Shilling V; Fallowfield L; Howell A; Hutton S
Psychooncology; 2004 Jan; 13(1):61-6. PubMed ID: 14745746
[TBL] [Abstract][Full Text] [Related]
18. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J
J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
[TBL] [Abstract][Full Text] [Related]
19. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
[TBL] [Abstract][Full Text] [Related]
20. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
